NEW APPROACHES TO COMPLEX CORRECTION HYPOTHYROIDISM AND ITS RELATED COMPLICATIONS

Authors

  • Malova N. G. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Sergiyenko L.Yu. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Komarova I. V. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Sirotenko L. A. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Spiridonov A. V. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Anikeyeva K. S. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv

DOI:

https://doi.org/10.21856/j-PEP.2016.4.10

Keywords:

thyroid, bone, hypothyroidism, osteoporosis, endocrine, chemical compounds

Abstract

It was studied the specific multipotent performance synthetic compounds with a number of tryazolopyrymides 7-(3-hydroxyphenyl)-6-carbetoxy-5-methyl-4,7-dihydro[1,2,4]triazolo [1,5-a]pyrymidyn (NE-99) in thyroid and skeletal system of Wistar rats with experimental hypothyroidism. It was proved the positive effect of the compound YV-99 on the structure and functions of the thyroid gland and found it osteoprotect effect on bone lumbar vertebrae experimental animals. The obtained data allow us to consider this compound as a comprehensive tool to correct hypothyroidism thyroid and endocrine concomitant osteoporosis.

References

Osteoporoz: jepidemiologija, klinika, profilaktika i lechenie: Monografija, pod red. Korzha NA, Povoroznjuka VV, Deduh NV, et al., Har’kov, 2002: 648 p.

Podrushnjak EP. Osteoporoz — problema veka, Simferopol’, 1997: 216 p.

Ferrari S, Bianchi ML, Eisman JA, et al. Osteoporos Int 2012; 23:2735-2748. doi: http://dx.doi.org/10.1007/s00198-012-2030-x

Hofbauer LC, Hamann C, Ebeling PR. Eur J Endocrinol 2010; 162:1009-1020. doi: http://dx.doi.org/10.1530/EJE-10-0015

Povoroznjuk VV, Podrushnjak EP, Orlova EV, et al. Osteoporoz na Ukraine, Kiev, 1995: 48 p.

Gensens P. Osteoporosis in clinical practice. A practical guide for diagnosis and treatment, London, 1998: 188 p.

Lee J, Vasikaran S. Ann Lab Med 2012; 32:105-112. doi: http://dx.doi.org/10.3343/alm.2012.32.1.82

Adler RA. Clin Biochem 2012; 45:894-900. doi: http://dx.doi.org/10.1016/j.clinbiochem.2012.01.024

Smith R. Med Int 1990; 73:3038-3040.

Fitzpatrick LA. Mayo Clin Proc 2002; 77:453-468. doi: http://dx.doi.org/10.4065/77.5.453

Polymeris A, Michalakis K, Sarantopoulou V. Endocr Regul 2013; 47:137-148. doi: http://dx.doi.org/10.4149/endo_2013_03_137

Franke Ju, Runge G. Osteoporoz, Moskva, 1995: 300 p.

100 izbrannyh lekcij po jendokrinologii (vtoroj vyp.), pod red. Karachenceva JuI, Kazakova AV, Kravchun NA, et al., Har’kov, 2014: 1000 p.

100 izbrannyh lekcij po jendokrinologii (vtoroj vyp.), pod red. Karachenceva JuI, Kazakova AV, Kravchun NA, et al., Har’kov, 2015; 2: 456 p.

Fadeev VV. Lechashhij Vrach 2005; 3:26-29.

Mytnyk ZM, Danova MG, Krushyns’ka ZG, et al. Mizhnar Endokrynol Zhurn 2008; 3(15):8-15.

Pan’kiv VI. Endokrynologija 2006; 11:134-137.

Olijnyk VA. Zhurn Prakt Likarja 2001; 2:5-7.

Kravchun NA, Chernjavskaja IV. Probl Endokryn Patologii’ 2011; 3:27-33.

Spuzjak MI. URZh 1996; 4(4):322–335.

Tremollieres F, Pouilles M, Larvet JP, Ribot C. Rev Rhum Mal Osteoartic 1991; 58:869-875.

Marova EI, Ahkubekova NK, Rozhinskaja LJa, et al. Osteoporoz i Osteopatii 1999; 1:13-17.

Kraiem Z. Thyroid 2005; 15(4):336-339. doi: http://dx.doi.org/10.1089/thy.2005.15.336

Yoshihara HA, Scanlan TS, Nguyen NH. Curr Top Med Chem 2003; 3(14):1601-1616. doi: http://dx.doi.org/10.2174/1568026033451682

Scanlan TS, Yoshihara HA, Chiellini G, et al. Curr Opin Drug Discov Devel 2001; 4(5):614-622.

Garg N, Li YL, Garcia Collazo AM, et al. Bioorg Med Chem Lett 2007; 17(15):4131-4134. doi: http://dx.doi.org/10.1016/j.bmcl.2007.05.049

Haning H, Mueller U, Schmidt G, et al. Bioorg Med Chem Lett 2007; 17(14):3992-3996. http://dx.doi.org/10.1016/j.bmcl.2007.04.085

Eksperymental’ne obg’runtuvannja zastosuvannja kriokonservovanyh preparativ embriofetoplacentarnogo kompleksu ta novyh himichnyh spoluk dlja korekcii’ patologij shhytovydnoi’ zalozy: zvit pro NDR, Harkiv, 2007; DR 0105U000983: 244 p.

Malova NG, Komarova IV, Jurchenko TM, et al. Problemni pytannja endokrynologii’ u vikovomu aspekti: materialy nauk.-prakt. konf. z mizhnar. uchastju, Harkiv, 2009: 79-80.

Poshuk novyh zasobiv terapii’ zahvorjuvan’ shhytovydnoi’ zalozy na osnovi biologichno aktyvnyh rechovyn riznogo pohodzhennja: zvit pro NDR, Harkiv, 2010; DR 0108U001149: 251 p.

Patent 56977 UA. 7-(3-Gidroksyfenil)-6-karbetoksy-5-metyl-4,7-dygidro[1,2,4]tryazolo-[1,5-a]pirymidyn, shho stymuljuje funkcional’nu aktyvnist’ shhytopodibnoi’ zalozy.

Doklinichni doslidzhennja likars’kyh zasobiv: metodychni rekomendacii’, za red. Stefanova OV, Kyiv, 2001: 528 p.

Zagal’ni etychni pryncypy eksperymentiv na tvarynah. Endokrynologija 2003; 3(1):142-145.

Second National Congress of Bioethics, Kyiv, 2004: 303 p.

Sarkisov DS, Perov JuL. Mikroskopicheskaja tehnika, Moskva, 1996: 542 p.

Gistologija: uchebnik, pod red. Afanas’eva JuA, Jurinoj NA, Moskva, 2002: 294-502.

Plohinskij NA. Matematicheskie metody v biologii, Moskva, 1978: 285 p.

Downloads

Published

2021-06-24

How to Cite

Malova, N. G., Sergiyenko, L., Komarova, I. V., Sirotenko, L. A., Spiridonov, A. V., & Anikeyeva, K. S. (2021). NEW APPROACHES TO COMPLEX CORRECTION HYPOTHYROIDISM AND ITS RELATED COMPLICATIONS. Problems of Endocrine Pathology, 58(4), 71-81. https://doi.org/10.21856/j-PEP.2016.4.10

Most read articles by the same author(s)